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Abstract
Objectives No nationwide paediatric reference standards
for bone mineral density (BMD) are available in China. We
aimed to provide sex-specific BMD reference values for
Chinese children and adolescents (3–18 years).
Methods Data (10 818 participants aged 3–18 years)
were obtained from cross-sectional surveys of the China
Child and Adolescent Cardiovascular Health in 2015, which
included four municipality cities and three provinces. BMD
was measured using Hologic Discovery Dual Energy X-ray
Absorptiometry (DXA) scanner. The DXA measures were
modelled against age, with height as an independent
variable. The LMS statistical method using a curve fitting
procedure was used to construct reference smooth crosssectional centile curves for dependent versus independent
variables.
Results Children residing in Northeast China had the
highest total body less head (TBLH) BMD while children
residing in Shandong Province had the lowest values.
Among children, TBLH BMD was higher for boys as
compared with girls; but, it increased with age and height
in both sexes. Furthermore, TBLH BMD was higher among
US children as compared with Chinese children. There was
a large difference in BMD for height among children from
these two countries. US children had a much higher BMD
at each percentile (P) than Chinese children; the largest
observed difference was at P50 and P3 and the smallest
difference was at P97.
Conclusions This is the first study to present a sexspecific reference dataset for Chinese children aged 3–18
years. The data can help clinicians improve interpretation,
assessment and monitoring of densitometry results.

Introduction
Osteoporosis, as a widespread metabolic
bone disease, has become a global public
health problem. More than 200 million
people worldwide and 10 million people in
the US were afflicted with osteoporosis in
2013.1 In China, the population with osteoporosis in 1997 was 83.9 million, which
is projected to increase to 212 million by

Strengths and limitations of this study
►► It is the first study to present a sex-specific refer-

ence dataset for Chinese children aged 3–18 years.
►► A number of reference curves were developed using

objective measures from DXA.
►► The large sample size enabled us to construct sta-

ble reference curves and extended previous studies
though covering a wide range of ages: from 3 to 18
years.
►► The data collected were not nationally representative; hence, we could not generalise the results to
the entire Chinese paediatric population.
►► Our developed reference curve could not be used
alone as a clinical criteria for the diagnosis of paediatric osteoporosis.

2050.2 The burdens associated with osteoporosis are heavy, with the most common
being fractures. It has been estimated that
the treatment cost for hip fracture, in China,
would be more than 85 billion Chinese
Yuan (ie, about US$13 billion) in 2020, and
1800 billion Chinese Yuan (ie, about US$271
billion) in 2050.3
Peak bone mass is an important determinant for osteoporotic fracture risk. A higher
peak bone mass is associated with lower risk
of osteoporotic fractures later in life.4 In
general, individuals have peak bone mass
in their early 20s; however, it may occur
earlier in women.5 6 Thus, investigating the
pattern of bone mineralization in children is
of great interest. Dual-energy X-ray absorptiometry (DXA) has been recommended by
the International Society for Clinical Densitometry (ISCD)7 as a current criterion for
measuring body mineral content (BMC) and
bone mineral density (BMD). This measurement method has high precision, accuracy,
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speed, low radiation exposure, ease of use and a strong
correlation with established methods.8–14
Paediatric osteoporosis is defined as having a history
of pathological fractures and low bone mineral content
or density.15 To diagnose paediatric osteoporosis, DXA
is the most widely used bone densitometry technique in
children.7 Although 60% of peak bone mass is genetically
determined, the increase of bone mass can be influenced
by other factors, including intake of dietary products
(eg, calcium and vitamin D) and weight-bearing physical
activity (eg, jumping).16
While diagnosing children can be problematic due to a
lack of a widely used reference, the Bone Mineral Density
in Childhood Study has developed an online BMD z-score
calculator for healthcare providers.17. Widespread reference for multiple diagnostic measurements is important
to ensure correct diagnosis among children so that
treatment and management for osteoporosis can begin.
Uniformity in diagnosis is also imperative for public
health so that epidemiological studies can be done across
geographic regions, ethnicities and social economic
status to properly inform prevention practices.
For children, DXA can be used to measure whole body
bone area (cm2) and whole body BMC (g), leading to BMD
(ie, BMC divided by bone area (g/cm2)), which indicates
the paediatric bone status. The use and correct identification of indicators for BMD is particularly important;
this requires appropriate reference data that are matched
for multiple factors including sex,18–20 chronological age,
height, weight, pubertal development and ethnicity.18 21–23
The preferred skeletal sites are lumbar spine (L1–L4) and
total body, excluding the head.24 The cranium should not
be included for the total body scan analysis, because the
head constitutes a large portion of the total body bone
mass but changes little with growth, activity or disease.
Thus, including the skull is likely to mask gains or losses
at other skeletal sites.25
Childhood and adolescence are critical periods for
bone growth, with half of peak bone mass developed
in childhood. If BMD could be evaluated in childhood
and adolescence, and children with low BMD could be
intervened on, then peak bone mass can be improved
in adulthood. Subsequently, osteoporosis occurrence
can be delayed, and severity of osteoporosis can be
reduced. A number of studies have shown that optimal
BMC and BMD in childhood and adolescence would
reduce risk of osteoporotic fracture several decades
later.26 To date, no paediatric reference standards for
BMD are available in China. Furthermore, utilisation
of US measures based on reference values derived from
the US National Health and Nutrition Examination
Survey (NHANES) data might not be applicable for
Chinese paediatric populations. Therefore, it is critically important and urgent to develop reference values
of BMD for Chinese children based on data gathered
from Chinese children. These reference standards can
help clinicians have a better estimation of the percentile on which Chinese children’s DXA-measured bone
2

Figure 1 Flow chart of the participants’ recruitment, China
Child and Adolescent Cardiovascular Health (CCACH) Study.

parameter falls in reference to their age or height. The
aim of this study was twofold: (1) to develop sex-specific
reference percentile curves for Chinese children based
on a large, nationwide sample; and (2) to compare our
findings with those of the study conducted by Kelly and
colleagues27 using US NHANES data.
Methods
Participants
The American Heart Association defined a new concept
of ‘ideal cardiovascular health (CVH)’ for American
adults and children in 2010,28 which included four health
behaviours (non-smoking, physically active, normal body
mass index (BMI) and healthy diet) and three health
factors (normal blood pressure, total cholesterol  and
fasting glucose). Based on these seven health behaviours
and factors, the construct of CVH comprehensively
combines the traditional risk factors proposed by the
Framingham Heart Study, as well as lifestyle behaviours,
emphasising the importance of overall strategies in
achieving optimal CVH. Our data were obtained from
the China Child and Adolescent Cardiovascular Health
(CCACH) Study. It is a large, nationwide, ongoing study
designed to examine CVH, BMD, body composition and
daily sodium intake among Chinese children aged 3–18
(figure 1). A stratified cluster random sampling method
was used to extract 100 children per age group in each
cluster (50 boys and 50 girls). Because the majority
of children were Han, accounting for 90% of the total
Chinese paediatric population, CCACH study mainly
collected CVH data among Han children. Children
were recruited from seven provinces (centres) covering
geographical areas in North, East, Northeast, Northwest
and Southwest regions of China, across latitude 29.6°
north to latitude 41.7° north (see online supplementary
figure 1). Eight exclusion criteria were: (1) the inability
to give informed consent; (2) any condition, or use of
any drug known to affect bone health; (3) non-removable objects (eg, prostheses, implants or casts); (4) body
weight greater than 204 kg, height greater than 197.5 cm
or weight or height beyond the measurement range of
Liu J, et al. BMJ Open 2018;7:e014542. doi:10.1136/bmjopen-2016-014542
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machines; (5) participation in research involving ionising
radiation in the past year; (6) no history of bone fracture;
(7) some chronic diseases and (8) pregnancy. Among
the 15 548 eligible participants, 11 057 agreed to participate and signed written informed consent documents.
Data were collected on 11 457 children; of these, 400
Hui children were excluded, 109 were excluded due to
kidney or thyroid disease, and 130 were excluded because
of implausible values of weight (light or heavy, BMI ≥3
SDs). Consequently, 10 818 children (5509 males and
5309 females) were used in the final analysis.
The study was approved by the Research Ethics
Committee of Capital Institute of Pediatrics of China.
The written informed consent documents for children
were obtained from their parents or guardians.
DXA acquisition and quality control
The whole-body scans were performed using Hologic
Discovery (A, W and Wi) fan-beam densitometers
(Hologic, Bedford, Massachusetts, USA). The coefficient of variation (CV%) was used as the quality control
procedure. CV% of A, W and Wi was 0.471%, 0.302% and
0.358%, respectively. Following the recommendations of
the ISCD, a high level of quality control was maintained
throughout the DXA data collection and scan analysis.
The specific procedures were as follows: (1) Standard
phantom was checked before scanning the participants
and calibrating of the DXA machines every morning; (2)
an operator at each study location was trained and the
same technician certified by ISCD administered DXA
procedures. The training materials included the ISCD’s
official technician hands-on training materials and the
manufacturer’s handbook including testing procedures
and operation methods; (3) at each centre, lumbar spine
and hip joints of 15 participants were scanned three times
for the calculation. After each scan, they had to leave the
scanner to repose before the next scan. All our operator
staff passed the precision quality control required by
ISCD, which controlled the CV% to less than 1.9% for
lumbar spine scans, 1.8% for hip joint scans and 2.5% for
femoral neck scans (see table 1) and (4) all participants

Table 1 The distribution of coefficient of variation (CV,
%) for lumbar spine, hip joint and femoral neck by study
location, the China Child and Adolescent Cardiovascular
Health (CCACH) Study (n=10 818)
Province/
Centre

Lumbar spine

Hip joint

Femoral neck

Beijing
Shanghai

0.88
0.97

1.42
1.34

1.91
2.33

Tianjin

1.06

1.02

1.99

Chongqing

0.59

1.62

2.05

Jilin

1.58

1.79

1.39

Shandong
Ningxia

1.11
1.25

1.79
1.07

1.97
1.89
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were requested to remove outer garments and objects that
would potentially interfere with testing. All DXA values
were analysed using Hologic Apex software Version 4.0
following the manufacturer’s guidelines.
Statistical analysis
The DXA measures for our paediatric participants were
modelled against age or height as the independent variable. The LMS statistical method (LMS ChartMaker Pro
Version 2.54)29 30 using a curve fitting procedure was
employed to construct reference smooth cross-sectional
centile curves for BMD/body composition versus age or
height. The LMS technique estimates three parameters:
median (M), coefficient of variation (S) and power in the
Box-Cox transformation (L). This summarises the distribution of the dependent variable given the covariate by
L depending on the skewness of the distribution while
M and S gives smooth curves for the dependence of L,
M and S on the covariate. These three parameters vary
as a function of independent variables fully describing
the reference data. Once these parameters are estimated,
then centile curves can be constructed using the formula
that has been described elsewhere.10 21 To avoid overfitting of the curves, parsimonious models were used
instead of complex models when they had similar goodness of fit. After fitting the curves, the distribution of
z-scores was observed and outlier analysis was performed
to verify that all values were within physiological range
(eg, observations ≥3 SDs were removed). All the analyses
were performed using SAS Version 9.4.The z-scores were
calculated by the following equation:
Z =

( X )L
M

LS

−1



If L=0,
Z=ln(X/M)/S
Where X is the TBLH BMD, L is the power transformation, M is the median value and S is the population SD24
Percentiles were obtained from z-scores, for example,
z-scores of −1.645,–1.282, 0, 1.282 and 1.645 correspond to the 5th, 10th, 50th, 90th and 95th percentiles,
respectively.
Results
Among the 10 818 children residing in seven geographically distributed centres across China, children from
Beijing accounted for the largest proportion (16.2%),
while children from Ningxia accounted for the smallest
proportion (12.2%) (table 2). In addition, the age- and
sex-specific TBLH BMD was significantly different among
seven centres. Children residing in Northeast China had
the highest TBLH BMD while children residing in Shandong Province had the lowest value (table 2).
TBLH BMD of children by sex and height is shown in
table 3. TBLH BMD increased with age for both sexes,
for example, from 0.412 g/cm2 at age 3 to 0.948 g/cm2 at
3
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Table 2 Geographical distribution of sample, The China Child and Adolescent Cardiovascular Health (CCACH) Study (n=10
818)
Geographical area

Province/Centre

Latitude

n

%

TBLH BMD

Northeast
North China

Jilin
Beijing

N 40°52’~46°18’
N39°26’~41°03’

1661
1739

15.4
16.1

0.785±0.160
0.734±0.151

Tianjin

N38°33’~40°15’

1653

15.3

Northwest

Ningxia

N35°14’~39°23’

1315

12.2

0.743±0.129

East China

Shanghai

N30°40’~31°53’

1613

14.9

0.740±0.131

Shandong

N34°25’~38°23’

1437

13.3

Chongqing

N28°10’~32°13’

1400

12.9

Southwest
F*
p

0.778±0.143
163.11
<0.0001

*Analysis of covariance, adjusted for age and sex.
BMD, bone mineral density; TBLH, total body less head.

age 18 for boys, and from 0.399 g/cm2 to 0.853 g/cm2 for
girls. Similarly, TBLH BMD also increased with height for
boys and girls. Overall, TBLH BMD was higher in boys
than in girls.
The percentiles of TBLH BMD among Chinese and US
children were compared and are shown in figure 2. TBLH
BMD increased with age among boys and girls in both
countries; however, TBLH BMD was comparatively higher
in children living in the US than those in China. Among
boys, the differences at each percentile (ie, P3, P50 and
P97) between China and the US were similar, in general;
the differences were small in young ages and peaked at
age 18. BMD at P3, P50 and P97 was higher in American
boys than in Chinese boys. There was a gradual increase
in BMD among girls and boys after age 14 and age 16,
respectively. Furthermore, BMD for age was higher in
boys than in girls in both countries.
In both China and the USA, BMD increased with height
in both sexes; US children had a much higher BMD than
Chinese children at each percentile, with the largest
difference at P50 and P3 and the least difference at P97.
The increasing rate of BMD for height was stable, with
an obvious increase from height 155 to 175 cm among
US children. Among girls with low heights (eg, <135 cm),
BMD value at P3 in US children was similar to BMD value
at P50 in Chinese children. A clear increase in BMD for
height was observed from 150 to 165 cm among US girls
as compared with increase in BMD from 145 to 155 cm
among Chinese girls. At height greater than 155 cm, the
difference in BMD became even larger. BMD peaked at
180 cm where BMD at P3 and P50 in US children were
close to those at P50 and P97 in Chinese children. BMD
for height was also higher in boys than in girls.
In each sex, LMS parameters and reference centiles of
BMD by age, BMD by height, fat mass percentage (FMP)
by age, fat mass index (FMI) by age and free fat mass
index (FFMI) by age can be found in online supplementary tables 1–10.
4

Discussion
In this study, we developed sex-specific reference standards using Hologic Discovery DXA scanner in a large
nationwide sample of Chinese children aged 3–18 years.
In addition, we compared the results from this study with
references used in NHANES data, and found that BMD
was lower in Chinese children than in US children. To
the best of our knowledge, this study is the first attempt to
develop reference BMD values for Chinese children using
a large nationwide paediatric population in China, and
compare it with alternative available references.
China has a vast territory with large populations.
Disparities in lifestyle behaviours, socioeconomic status,
obesity and metabolic disorders may contribute to differences in BMD among children and adolescents. There
is an urgent need to establish unified, nationwide BMD
reference standards for children and adolescents, to help
better evaluate their growth status. In addition, adequate
peak bone mass at an early age was positively associated
with lifelong health (eg, osteoporosis at an older age)16 31;
therefore, an accurate assessment of BMD is essential in
assisting development of future preventive methods to
reduce the physical and economic burden of osteoporosis.
The difference in BMD among children may be due
to their different dietary patterns. Compared with children consuming traditional Chinese diet (predominately
consisting of vegetables and grains, and featuring plantbased protein, which is high in fibre, and low in cholesterol and fat), children in Western countries are more
likely to consume foods that consists of more meats and
milk. Thus their diet is high in energy density, fat and
protein.32 Different genetic backgrounds should also be
an explanation for the difference in BMD among children
in China and the US. There are no reference standards
of BMD available for the Chinese paediatric populations
based on a large dataset. The present study utilised all
body and regional DXA data to establish age-, sex- and
height-specific reference values for Chinese children
Liu J, et al. BMJ Open 2018;7:e014542. doi:10.1136/bmjopen-2016-014542
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269

322

408

401

399

332

345

327

352

319

299

440

540

405

241

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

126

169

227

275

313

358

363

330

312

258

263

254

336

514

100

105

110

115

120

125

130

135

140

145

150

155

160

165

Height (cm)

110

3

Age (years)

Sample
size

Male

0.859±0.090

0.828±0.087

0.769±0.075
0.721

0.686

0.651

0.620

0.595

0.692±0.064

0.726±0.068

0.573

0.550

0.524

0.497

0.467

0.437

0.410

0.386

0.366

0.808

0.791

0.763

0.737

0.704

0.665

0.628

0.597

0.571

0.547

0.523

0.489

0.445

0.409

0.373

0.350

5th

0.667±0.054

0.642±0.053

0.604±0.046

0.577±0.045

0.538±0.044

0.504±0.037

0.463±0.028

0.434±0.024

0.401±0.025

0.948±0.093

0.953±0.094

0.916±0.096

0.877±0.085

0.845±0.075

0.798±0.075

0.748±0.071

0.709±0.068

0.673±0.059

0.644±0.052

0.610±0.051

0.582±0.050

0.531±0.046

0.479±0.039

0.444±0.037

0.412±0.030

Mean±SD

0.742

0.706

0.669

0.637

0.611

0.588

0.564

0.537

0.509

0.478

0.447

0.418

0.393

0.372

0.836

0.819

0.789

0.762

0.728

0.687

0.648

0.615

0.589

0.564

0.538

0.503

0.458

0.420

0.383

0.360

10th

0.831

0.788

0.745

0.708

0.677

0.649

0.620

0.588

0.555

0.519

0.483

0.449

0.420

0.395

0.949

0.927

0.891

0.858

0.818

0.771

0.725

0.687

0.656

0.627

0.596

0.557

0.505

0.463

0.421

0.395

50th

TBLH BMD percentiles

0.948

0.897

0.845

0.798

0.761

0.726

0.691

0.652

0.613

0.570

0.526

0.486

0.452

0.422

1.081

1.054

1.011

0.971

0.923

0.867

0.814

0.770

0.733

0.699

0.663

0.618

0.559

0.511

0.463

0.434

90th

0.989

0.934

0.878

0.829

0.789

0.752

0.714

0.674

0.632

0.586

0.540

0.498

0.462

0.431

1.123

1.094

1.048

1.006

0.956

0.898

0.842

0.795

0.757

0.721

0.684

0.636

0.576

0.526

0.476

0.446

95th

444

838

830

489

277

254

256

299

336

284

278

175

200

171

293

456

571

475

298

274

290

293

303

340

333

359

376

259

267

122

Sample
size

Female

0.855±0.066

0.829±0.065

0.813±0.070

0.784±0.078

0.722±0.079

0.662±0.068

0.630±0.057

0.600±0.053

0.566±0.050

0.534±0.042

0.492±0.035

0.459±0.030

0.428±0.025

0.396±0.024

0.853±0.068

0.853±0.068

0.843±0.068

0.829±0.062

0.818±0.061

0.800±0.071

0.765±0.069

0.722±0.071

0.670±0.072

0.629±0.061

0.595±0.055

0.557±0.049

0.515±0.047

0.470±0.036

0.426±0.032

0.399±0.025

Mean±SD

0.741

0.718

0.688

0.645

0.597

0.560

0.534

0.513

0.487

0.458

0.431

0.405

0.382

0.360

0.751

0.745

0.734

0.720

0.701

0.673

0.635

0.593

0.556

0.526

0.498

0.468

0.434

0.401

0.366

0.349

5th

0.762

0.739

0.709

0.665

0.615

0.576

0.548

0.526

0.499

0.468

0.439

0.413

0.389

0.366

0.771

0.766

0.755

0.741

0.724

0.696

0.658

0.615

0.576

0.544

0.514

0.482

0.446

0.411

0.374

0.357

10th

0.843

0.821

0.793

0.747

0.690

0.642

0.607

0.579

0.546

0.509

0.474

0.443

0.416

0.390

0.850

0.845

0.835

0.823

0.807

0.781

0.743

0.696

0.652

0.612

0.575

0.535

0.491

0.449

0.406

0.385

50th

TBLH BMD percentiles

0.932

0.913

0.892

0.848

0.787

0.732

0.689

0.653

0.611

0.563

0.519

0.480

0.447

0.417

0.938

0.933

0.922

0.911

0.897

0.873

0.834

0.784

0.734

0.687

0.642

0.594

0.542

0.492

0.441

0.417

90th

Continued

0.959

0.942

0.923

0.882

0.821

0.764

0.718

0.679

0.634

0.582

0.534

0.492

0.457

0.425

0.966

0.960

0.949

0.937

0.924

0.900

0.861

0.810

0.758

0.710

0.662

0.612

0.558

0.505

0.452

0.426

95th

TBLH BMD (g/cm2) of children aged 3 to 18 years by sex and height, The China Child and Adolescent Cardiovascular Health (CCACH) Study (n=10 818)

Age, height

Table 3
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BMD, bone mineral density; TBLH, total body less head.

–

–
–

–
–

–
–

–
–

–
–

–
–

–
1.134

1.088
1.041

1.084
0.943

0.908
0.808

0.838
0.813

0.784

222
180

0.977±0.103

432
175

0.930±0.095

0.980
0.953
0.864
0.783
0.761
0.878±0.076
120
1.040
0.997
0.871
0.776
0.753
670
170

0.896±0.086

95th
90th
50th
10th
5th

TBLH BMD percentiles

Mean±SD
Sample
size
50th
10th
5th

Sample
size
Age, height

Mean±SD

TBLH BMD percentiles

90th

95th

Female
Male

Continued
Table 3
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aged 3–18 years, and provided centile curves of BMD,
which can be used in both research and clinical settings.
DXA, a widely available technology, is capable of
providing regional measures of fat and lean mass. The
distribution of fat and lean mass is likely to predict health
outcomes,27 as shown previously in an adult sample.30
DXA measurements provide precise body composition analysis with a low radiation dose,33 and are able to
detect small changes in body composition. DXA devices
from different manufacturers might not give identical
results due to differences in calibration and bone edge
detection algorithms.34 Therefore, to calculate reliable
results, one should use reference data obtained with an
identical DXA device. For instance, US NHANES data
employed Hologic (Hologic, Bedford, Massachusetts)
and GE-Lunar as the two dominant DXA manufacturers.
Despite the similar DXA technology used for by manufacturers, the results of BMD and body composition can
be different due to proprietary techniques used, algorithms to calculate the BMD, as well as the regions of
interest. This leads to various DXA values for patients
who are scanned by different DXA systems.8 To avoid the
comparability problem, our study used Hologic as the
only manufacturer. We used our collected data on BMD
percentiles among Chinese children to compare with
those among US  children (BMD values were obtained
from US NHANES data).27
Compared with our study, another study,35 conducted
among southern Chinese paediatric populations, was
different in selected geographic characteristics, sample size
and age range. For example, although 900 children (5–19
years) came from Guangzhou (Southern China) and about
600 (14–19 years) came from Zhejiang (East China), the
study did not consider variation in geographic characteristics; and their age range was smaller than ours (3–18 years).
Equipment used in that study was GE Lunar, therefore their
results cannot be compared with ours, having used Hologic
DXA.
Our study has many strengths. First, we developed
a number of reference curves generated from objective measures from DXA including sex-age-specific and
sex-height-specific TBLH BMD, providing nationwide references for Chinese children. Second, the large sample size
enabled us to construct stable reference curves and extended
previous studies though covering a wide range of ages from 3
to 18 years. Third, our study followed the recommendation
of ISCD and studied TBLH BMD for Chinese children.
Several limitations are noteworthy. First, though our data
is nationally and geographically distributed across China, it
is not nationally representative; hence, the results may not
be generalisable to the entire Chinese paediatric population. For example, although Ningxia Province, representative of Northwest China, has thousands of Hui population,
we mainly collected data from schools including Han population. Thus, our sampled participants across China likely
only represent Chinese Han children. Moreover, our developed reference curve could not be used alone as a clinical
criteria for the diagnosis of osteoporosis. This is because:
Liu J, et al. BMJ Open 2018;7:e014542. doi:10.1136/bmjopen-2016-014542
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Figure 2 The percentiles of TBLH BMD among Chinese and US children by age and height. CN, data from China; TBLH BMD,
total body less head bone mineral density; US, data from NHANES.

(1) low bone mass may reflect only a small part of the true
burden of osteoporosis and (2) BMD could not demonstrate other important components of bone strength.
Despite these limitations, there are some important public
health implications. First, the BMD percentile can be
used to precisely evaluate child and adolescent growth,
and help high-risk populations become connected with
better interventions. Second, since childhood obesity has
been epidemic in the nation, assessing BMD can facilitate
association studies between body composition (eg, fat and
muscle) and bone health, to better determine health status
for obese individuals. Furthermore, it can be used for evaluating effectiveness of sports intervention among children.
Clinical implications are also notable. First, childhood
kidney disease, rheumatism and immune diseases, and
bone and joint diseases can directly and indirectly influence bone growth; Second, BMD tests can evaluate these
diseases’ adverse outcomes on an individual’s health status
and treatment effects. In addition, antiepileptic drugs and
other hormonal drugs can affect osteogenesis, and BMD
reference can be used as a standard for evaluation of treatment effects and side effects for children.
Conclusion
This is the first study to develop sex-specific references
among Chinese children aged 3–18 years using the Hologic
Liu J, et al. BMJ Open 2018;7:e014542. doi:10.1136/bmjopen-2016-014542

Discovery DXA scanner. The information can be used to
guide clinicians and improve interpretation, assessment and
monitoring of BMD results for Chinese children. However, it
needs to be combined with other indicators (eg, blood pressure, serum lipid and calcium-phosphorus metabolism) to
identify the diagnosis cut points for osteopenia.
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